Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery

A R Chade1, D Brosh, S T Higano

  • 1Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota 55902, USA.

Kidney International
|January 13, 2006
PubMed

Insights

Early chronic kidney disease (CKD) is linked to reduced coronary vasodilator capacity, even in patients without obstructive coronary artery disease. This suggests parallel microcirculation issues in kidneys and heart, increasing cardiovascular risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Microcirculation Research

Background:

  • Patients with chronic kidney disease (CKD) face higher cardiovascular event risks.
  • The link between CKD and coronary microvascular disease is not fully understood.
  • Early detection of microvascular dysfunction is crucial for cardiovascular risk stratification.

Purpose of the Study:

  • To investigate the association between early chronic kidney disease (CKD) and coronary microvascular disease.
  • To evaluate coronary vasodilator capacity in patients with normal or mildly diseased coronary arteries and varying levels of kidney function.
  • To determine if reduced glomerular filtration rate (GFR) correlates with impaired coronary flow reserve (CFR).

Main Methods:

  • Study included 605 patients with normal or mildly diseased coronary arteries undergoing angiography.
  • Coronary flow reserve (CFR) was assessed using intracoronary adenosine.
  • Patients were categorized based on estimated glomerular filtration rate (eGFR), with CKD defined as eGFR < 60 ml/min/1.73 m(2).

Main Results:

  • Patients with CKD (eGFR < 60 ml/min/1.73 m(2)) exhibited significantly lower CFR compared to those with normal GFR (eGFR ≥ 60 ml/min/1.73 m(2)).
  • The CKD group showed reduced CFR (2.6±0.6) versus the normal GFR group (3.0±0.8), with P<0.001.
  • Logistic regression confirmed reduced renal function as independently associated with attenuated coronary vasodilator capacity after adjusting for age, gender, and hypertension.

Conclusions:

  • Reduced renal function, indicative of early CKD, is associated with impaired coronary vasodilator capacity in patients without obstructive coronary artery disease.
  • The correlation between low GFR and reduced CFR suggests parallel alterations in renal and coronary microcirculation.
  • This microvascular impairment may signify an unmeasured risk factor, contributing to the heightened cardiovascular risk observed in CKD patients.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...